CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6852 result(s)

Acamprosate calcium (Campral)

Last Updated: July 22, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Acamprosate calcium
Indications: Alcohol Abstinence

  • Brand Name: Campral
  • Manufacturer: Prempharm Inc.
  • Project Number: S0143
  • Project Status: Complete
  • Submission Type: Request For Advice

Octreotide for Endocrine, Oncologic, and Gastrointestinal Disorders: Systematic Review and Budget Impact Analysis

Last Updated: July 21, 2008
Result type: Reports

Technologies Octreotide, which is a synthetic analogue of somatostatin, inhibits endocrine and exocrine secretions. Condition Octreotide is approved by Health Canada for use in acromegaly, neuroendocrine tumours, pancreatic surgery, and emergency bleeding of gastroesophageal varices. Octreotide is also being used for other unapproved indicati...

Octreotide for Endocrine, Oncologic, and Gastrointestinal Disorders: Systematic Review and Budget Impact Analysis

Last Updated: July 21, 2008
Result type: Reports

Technologies Octreotide, which is a synthetic analogue of somatostatin, inhibits endocrine and exocrine secretions. Condition Octreotide is approved by Health Canada for use in acromegaly, neuroendocrine tumours, pancreatic surgery, and emergency bleeding of gastroesophageal varices. Octreotide is also being used for other unapproved indicati...